Mary S. Brady

16.5k total citations
106 papers, 4.7k citations indexed

About

Mary S. Brady is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Mary S. Brady has authored 106 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 23 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Mary S. Brady's work include Cutaneous Melanoma Detection and Management (60 papers), Nonmelanoma Skin Cancer Studies (21 papers) and Melanoma and MAPK Pathways (14 papers). Mary S. Brady is often cited by papers focused on Cutaneous Melanoma Detection and Management (60 papers), Nonmelanoma Skin Cancer Studies (21 papers) and Melanoma and MAPK Pathways (14 papers). Mary S. Brady collaborates with scholars based in United States, Australia and United Kingdom. Mary S. Brady's co-authors include Daniel G. Coit, Klaus J. Busam, Katherine S. Panageas, Ami B. Patel, Paul Russo, Christian P. Pavlovich, Stuart H. Q. Quan, Jeffrey P. Kavolius, Dimitrios P. Mastorakos and Marianne Berwick and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Mary S. Brady

103 papers receiving 4.6k citations

Peers

Countries citing papers authored by Mary S. Brady

Since Specialization

Citations

This map shows the geographic impact of Mary S. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary S. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary S. Brady more than expected).

Fields of papers citing papers by Mary S. Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary S. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary S. Brady. The network helps show where Mary S. Brady may publish in the future.

Co-authorship network of co-authors of Mary S. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Mary S. Brady. A scholar is included among the top collaborators of Mary S. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary S. Brady. Mary S. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma 2020 ·British journal of surgery ·Edmund K. Bartlett, Ann Y. Lee, Philip M. Spanheimer, Danielle M. Bello, Mary S. Brady, Charlotte E. Ariyan, Daniel G. Coit	9
2	Merkel Cell Carcinoma Of The Skin 2020 ·StatPearls ·Mary S. Brady, (unknown)	1
3	ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma 2020 ·Annals of Surgical Oncology ·Yinin Hu, Mary S. Brady	2
4	Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis 2015 ·Oncotarget ·(unknown), (unknown), Joya Sahu, Mary S. Brady, Natalia A. Riobo‐Del Galdo, Mỹ G. Mahoney	16
5	Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma 2013 ·Annals of Surgical Oncology ·David Gyorki, Jianda Yuan, Zhenyu Mu, Bushra Zaidi, Melissa Pulitzer, Klaus J. Busam, Mary S. Brady, Daniel G. Coit, James P. Allison, Jedd D. Wolchok, Charlotte E. Ariyan	42
6	Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma 2012 ·Melanoma Research ·Giorgos C. Karakousis, Neeta Pandit‐Taskar, Meier Hsu, Katherine S. Panageas, (unknown), Charlotte E. Ariyan, Mary S. Brady	7
7	Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma 2011 ·Cancer ·Ryan C. Fields, Klaus J. Busam, Joanne F. Chou, Katherine S. Panageas, Melissa Pulitzer, Peter J. Allen, Dennis H. Kraus, Mary S. Brady, Daniel G. Coit	73
8	Phase II trial of neoadjuvant temozolomide in resectable melanoma patients 2010 ·Annals of Oncology ·Gaurav Shah, Nicholas D. Socci, Jason S. Gold, Jedd D. Wolchok, (unknown), K. Panageas, Agnès Viale, Mary S. Brady, Daniel G. Coit, Paul B. Chapman	30
9	Histologic Distinction Between Subungual Lentigo and Melanoma 2008 ·The American Journal of Surgical Pathology ·Bijal Amin, Kishwer S. Nehal, Achim A. Jungbluth, Bushra Zaidi, Mary S. Brady, Daniel Coit, (unknown), Klaus J. Busam	63
10	Subungual melanoma: management considerations 2008 ·The American Journal of Surgery ·Tzeela Cohen, Klaus J. Busam, Ami B. Patel, Mary S. Brady	71
11	Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma 2007 ·Journal of Clinical Oncology ·Rebecca C. Taylor, Ami B. Patel, Katherine S. Panageas, Klaus J. Busam, Mary S. Brady	224
12	Primary Cutaneous Melanoma with Regression Does not Require a Lower Threshold for Sentinel Lymph Node Biopsy 2007 ·Annals of Surgical Oncology ·Katherine T. Morris, Klaus J. Busam, (unknown), Ami B. Patel, Mary S. Brady	57
13	Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma 2006 ·Annals of Surgical Oncology ·Sandra L. Wong, Mary S. Brady, Klaus J. Busam, Daniel G. Coit	94
14	Utility of Preoperative [(18)]F Fluorodeoxyglucose–Positron Emission Tomography Scanning in High-Risk Melanoma Patients 2006 ·Annals of Surgical Oncology ·Mary S. Brady, Timothy Akhurst, Kathryn Spanknebel, Susan Hilton, Mithat Gönen, Ami B. Patel, Steven M. Larson	62
15	Cutaneous melanoma arising in a burn scar: two recent cases and a review of the literature 2006 ·Melanoma Research ·(unknown), Klaus J. Busam, Mary S. Brady	9
16	Sentinel Lymph Node Mapping in Patients With Cutaneous Melanoma 2004 ·Dermatologic Surgery ·Mary S. Brady	0
17	Lymphatic Mapping in the Management of Melanoma in Children 1998 ·Pediatric Dermatology ·Mary S. Brady, (unknown), Dennis H. Kraus, Jonathan J. Lewis, Daniel G. Coit, Michael P. LaQuaglia, Klaus J. Busam	6
18	Cutaneous melanoma in patients with sarcoma 1997 ·Cancer ·Carola Berking, Mary S. Brady	9
19	Malignant mesenchymoma 1996 ·Cancer ·Mary S. Brady, (unknown), Giovanni Tallini, Paul Russo, James M. Woodruff	25
20	Immune Interferon Is a Growth Factor for Human Lung Fibroblasts ^1– ⁴ 1986 ·American Review of Respiratory Disease ·Gary W. Hunninghake, (unknown), Mary S. Brady, Martha M. Monick	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact